Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

UK's Johnson Matthey sells unit to Honeywell

The Wall Street Journal on MSN · 8h
Honeywell to Buy Johnson Matthey’s Catalyst Unit for $2.4 Billion
The U.S. industrials conglomerate agreed to buy Johnson Matthey’s catalysts unit, lifting shares in the British platinum refiner.
Financial Times · 1d
Honeywell buys Johnson Matthey catalyst unit in £1.8bn deal
US industrials group Honeywell is close to securing a £1.8bn all-cash deal to buy the catalyst technologies arm of FTSE 250 chemicals company Johnson Matthey.
Reuters on MSN · 1d
Johnson Matthey soars on $2.4 billion unit sale to Honeywell
UK chemicals company Johnson Matthey has agreed to sell its catalyst technologies business to Honeywell International for 1.8 billion pounds ($2.4 billion), including debt, it said on Thursday, driving its shares up by a third.
23hon MSN
Honeywell expansion spree continues with $2.4B deal to buy part of UK company
In its latest expansion move, Honeywell reached a $2.4 billion agreement to acquire a British chemical company’s catalyst ...
7h
Johnson Matthey PLC (JMPLF) Full Year 2025 Earnings Call Highlights: Strategic Divestment and ...
Johnson Matthey PLC (JMPLF) reports significant growth in Catalyst Technologies and Clean Air margins, alongside a major ...
1don MSN
UK's Johnson Matthey sells unit to Honeywell for $2.4 billion
(Reuters) -British chemicals firm Johnson Matthey has agreed to sell its division that houses technologies to make ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy